Skip to main content
. 2022 Apr 22;134(2):57. doi: 10.1007/s12039-022-02046-0

Figure 7.

Figure 7

2D representation depicting docking interactions of tirilazad with SARS-CoV-2 protein targets (A) 3CLpro (−8.7 kcal/mol) (B) PLpro (−7.9 kcal/mol) (C) NSP12 (−9.7 kcal/mol) and (D) NSP16 (−11.4 kcal/mol).